Drugs and biologicals

Ended Awarded

Contract number
HHSN26300002
Awardee
Awarding agency
Obligated
$4,306

Award facts

Contract value 100% obligated
$4,305.88 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Walkersville, MD 21793, USA

Award details come from SAM.gov/FPDS.

About this award

On January 6, 2016, the Office of the Director (Civilian agency) awarded a Blanket Purchase Agreement (BPA) call to Lonza Walkersville, Inc. for drugs and biologicals with a ceiling value of $4,305.88. The contract is firm fixed price with an ultimate completion date of December 31, 2016, and will be performed at Lonza's facility in Walkersville, Maryland. No set-aside designation was used for this procurement, indicating open competition. Lonza Walkersville, Inc., a foreign-owned, for-profit manufacturer specializing in biological materials and laboratory equipment, has been registered in SAM.gov since 2002 and serves as a critical supplier to federal research institutions, particularly within the biomedical and life sciences sectors.

This award represents a task order call against Lonza Walkersville's existing single-award BPA with the Health and Human Services Office of Logistics and Acquisition Operations, valued at $10 million and valid through December 31, 2025. The BPA facilitates streamlined procurement of biological materials, blood products, media products, laboratory supplies, and medical and scientific equipment for multiple National Institutes of Health institutes and research centers. As a subsidiary of the global Lonza Group, the company has consistently provided specialized research equipment and materials to federal agencies including the National Institutes of Health, Food and Drug Administration, Department of Veterans Affairs, and various NIH institutes focused on cancer research, infectious diseases, regenerative medicine, and cellular engineering.

Quick answers

Who was awarded contract HHSN26300002?

HHSN26300002 was awarded to Lonza Walkersville, Inc. by Office of the Director (National Institutes of Health) on January 6, 2016.

How much is contract HHSN26300002 worth?

The government has obligated $4,306 on HHSN26300002.

Is contract HHSN26300002 an order under another contract?

Yes. HHSN26300002 is a BPA call under HHSN263201600052B, a blanket purchase agreement.

Was contract HHSN26300002 competed?

The extent of competition for HHSN26300002 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award